Filing Details

Accession Number:
0001466049-11-000005
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-10 17:20:19
Reporting Period:
2011-02-08
Filing Date:
2011-02-10
Accepted Time:
2011-02-10 17:20:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1322505 Biodel Inc BIOD Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1397446 Erik Steiner C/O Biodel Inc.
100 Saw Mill Road
Danbury CT 06810
Vice-President, Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-02-08 1,250 $0.00 264,270 No 4 M Direct
Common Stock Disposition 2011-02-10 10,000 $2.08 254,270 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Acquisiton 2011-02-08 1,250 $0.00 1,250 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2011-02-08 2011-02-08 No 4 M Direct
Footnotes
  1. Each Restricted Stock Unit was the economic equivalent of one share of common stock. The shares of common stock were distributed upon settlement of vested Restricted Stock Units originally granted on December 15, 2009.
  2. This transaction was executed in multiple trades at prices ranging from $2.07 to $2.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.